Flow Lab—Minutes Away From our Clinical Unit
Benefits of Partnering with Altasciences for Your Flow Cytometry Services
Our bioanalytical laboratory is located 15 minutes from our Montréal clinical pharmacology unit, creating an efficient process that allows rapid turnaround time between sample collection and analysis.
The close proximity between the clinic and our lab:
- prevents potential risks at the primary endpoints of these types of trials
- certifies rapid results analysis and reporting
- ensures safe and seamless dose escalations for FIH trials
- proven to lower costs
To safely expedite the bioanalytical phase of your preclinical or clinical study or program, our flow cytometry services will help you get there.
Book a consult with one of our experts today, to discuss how we can support your single study or program.
You may also be interested in the following:
- Webpage:
- Podcast:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programmes, to offer an integrated/synchronized approach to CRO and CDMO services.
Accelerate the Development of Your CNS-Active Drugs with Pharmacodynamic Measures
Accelerate the Development of Your CNS-Active Drugs with Pharmacodynamic Measures
Strategic design and targeted use of pharmacodynamic measures can greatly assist in evaluating the safety and potential efficacy of your new drug candidate in the early stages of clinical development.
In this on-demand webinar, our experts discuss how to include validated models of pain, anxiety, and other psychiatric conditions as part of a battery of tests for cognition and safety, to evaluate a drug’s potential for abuse or dependence, as well as its ability to enhance or impair performance.
You may also be interested in the following:
- The Altascientist: Considerations for Your CNS-active Drug Development Program
- Webinar — Assessing Cognition and Driving Ability in Clinical Pharmacology Studies
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programmes, to offer an integrated/synchronized approach to CRO and CDMO services.
Formulation to Clinic―Navigating the Complexities of Ophthalmic Drug Development
Helping You Navigate the Complexities of Ophthalmic Drug Development
Ophthalmic drug development comes with a unique set of challenges and complexities. To maximize your chance of success, it is best to rely on a drug development partner with regulatory knowledge, scientific and technical expertise, and a thorough understanding of the market in this growing therapeutic area.
Altasciences’ clients benefit from working with a single CRO/CDMO partner, from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in both time and cost savings.
Learn about the key considerations and critical steps in each phase of ophthalmic drug development, including case studies, in this issue of The Altascientist.
Have questions? Speak with one of our experts.
You might also be interested in:
- Webpage: Full-Service Drug Development Solutions
- Scientific Article: Terminal Sterilization of Pharmaceutical Products
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Five Reasons to Place Early Phase Clinical Research in Canada
A well-planned clinical program designed to meet the regulatory requirements for the jurisdictions where you plan to request market authorization can be conduct
Data Excellence—the Core of Drug Development
Trust Altasciences to Deliver the Quality, Compliant Data You Need
How do we collect data? With much planning!
Your study plan documents complement your protocol, and provide additional details for data management and analysis.
Our data managers plan for quality, clear data in support of your regulatory submission. Single- or multi-site, in a wide range of therapeutic areas, our decades of experience will deliver the data you need.
Let’s talk data—contact our experts today!
Have an extra minute? Take a look at these:
- Blog: Data Management Excellence–What it Takes
- Webpages:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
Access Earlier Clinical Data to Accelerate Your Program
Phase I and II Combined Protocols Can Give You Earlier Access to Important Data—Here’s How
Have you considered combining Phase I and II protocols to advance certain analyses? Think DDI, QT assessment, food, age, or gender affect, or cognitive or dependence evaluation. With earlier access to this highly relevant data, you have the power to make more informed decisions as you progress your drug through development, and possibly obtain a waiver for certain later-phase studies.
Our experts in protocol development are ready to design your ideal program, giving you the earliest, most complete understanding of your developmental product.
Read The Altascientist for a more complete discussion on combined protocols, including two scenarios.
DOWNLOAD your copy, or listen to the AUDIOBOOK.
Have five more minutes? Browse these webpages for more important information:
- First-in-Human Clinical Trials
- Early Phase Drug Development Solutions
- Clinical Development Solutions
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO service
Managing Challenging Bioanalysis for PK/PD Assessments for Phase I Biologics Studies
How to Maximize Drug Development Success of Biologics
Combining Phase I trial conduct of biologics and bioanalysis is critical for successful drug development. Clinical development relies heavily on bioanalytical experts to generate critical data to understand pharmacokinetics and pharmacodynamics.
Here are just some of the benefits of working with Altasciences:
- Timed interim sample analysis for dose escalation decisions
- Rapid turnaround of PK/PD analysis between cohorts
- Biomarker development and validation for exploratory or primary endpoints
- On-site flow cytometry
- Centralized scheduling between clinic and lab
- Ability to easily switch or combine platforms which are sensitive, have high throughput, and demonstrate exquisite specificity
Watch this complimentary webinar to see how you can overcome challenges throughout all phases of drug development.
Have 5 minutes? Take a look at these:
- How Is Partnering with Altasciences for Your First-in-Human Clinical Trials Different?
- Microsampling in Drug Development
- Validated Bioanalytical Assay List
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Clinical Research… Beyond the Trial
Comprehensive Clinical Research Support
A successful clinical trial is more than just conduct. A complete suite of integrated, research support services and expert scientific input are key to reaching your study goals.
Enhance your drug development program with Altasciences’ research support services, whether as stand-alone offerings or as part of a complete program. Your chosen partners become ours, and we act as integral contributors, applying decades of knowledge and expertise, and moving in unison to deliver the highest quality results.
Let us know how we can support you!
Have five minutes? Take a look at these:
- Fact Sheet: Comprehensive Research Support Offering
- Webpage: Research Support Capabilities
- eBook: One Integrated Solution for Your Preclinical to Clinical Drug Development Needs
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
How We Formulate Complex APIs Others Can’t
How We Succeed When Others Can’t
Andrew Buis, Senior Formulation Scientist at Altasciences, explains how we succeed in developing the most complex formulations when others fail, and even customize them based on specific client needs.
Points of discussion include:
- Our facility design, equipment, and experience
- What our recent 35,000-sq.-ft. expansion means for clients
- How we develop customized formulations
- How we formulated APIs for clients when others failed
Got 5 more minutes? Check out:
- Video: Manufacturing and Handling Highly Potent APIs and Controlled Substances
- Webpage: Altasciences’ Drug Development, Manufacturing, and Analytical Solutions
- Scientific Paper: Benefits of Liquid-Filled Capsules Versus Tablets in Pharmaceutical Development
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.